Related Experiment Video
Updated: Mar 11, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
A novel dominant D109A CRYAB mutation in a family with myofibrillar myopathy affects αB-crystallin structure
Jakub P Fichna1, Anna Potulska-Chromik2, Przemysław Miszta3
1Laboratory of Neurogenetics, Department of Neurodegenerative Disorders, Mossakowski Medical Research Center, Polish Academy of Sciences, 02-106 Warszawa, 5 Pawinskiego St., Poland.
Abstract:
Myofibrillar myopathy (MFM) is a group of inherited muscular disorders characterized by myofibrils dissolution and abnormal accumulation of degradation products. So far causative mutations have been identified in nine genes encoding Z-disk proteins, including αB-crystallin (CRYAB), a small heat shock protein (also called HSPB5). Here, we report a case study of a 63-year-old Polish female with a progressive lower limb weakness and muscle biopsy suggesting a myofibrillar myopathy, and extra-muscular multisystemic involvement, including cataract and cardiomiopathy. Five members of the proband's family presented similar symptoms. Whole exome sequencing followed by bioinformatic analysis revealed a novel D109A mutation in CRYAB associated with the disease. Molecular modeling in accordance with muscle biopsy microscopic analyses predicted that D109A mutation influence both structure and function of CRYAB due to decreased stability of oligomers leading to aggregate formation. In consequence disrupted sarcomere cytoskeleton organization might lead to muscle pathology. We also suggest that mutated RQDE sequence of CRYAB could impair CRYAB chaperone-like activity and promote aggregation of lens crystallins.
More Related Videos
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Cross-bridge Cycle
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils

